Citi analyst Mathieu Chevrier upgraded Sonic Healthcare to Buy from Neutral with a price target of A$36, up from A$34.50. The analyst believes the company’s earnings risk is to the upside on its "under geared" balance sheet and potential new contract in the U.K.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly